Time is key in treating stroke. Every minute of stroke kills about two million brain cells. My work integrates research and clinical advances to provide the best possible care for stroke. My goal is to minimize stroke brain damage and related disabilities, which are life altering and very expensive to care for over a patient’s lifetime. Our innovative stroke ambulance, for example, provides much better access to stroke care within the critical window of time for rural patients than was previously available, which is very important in Alberta.
Dr. Ashfaq Shuaib received his medical training at Khyber Medical College in Pakistan and his post-graduate training in Internal Medicine and Neurology at the University of Calgary. He completed specialized training in cerebrovascular research at the University of Western Ontario and Duke University Medical School in Durham, North Carolina.
He returned to Canada as an assistant professor in medicine and neurology at the University of Saskatchewan, becoming full professor in 1995. In addition, he was program director of the Division of Neurology between 1990 and 1995, supervised numerous research fellows and graduate students and was director of the Saskatchewan Stroke Research Centre and the WHO Centre.
He joined the University of Alberta as professor of medicine and director of the Division of Neurology in 1997.
Leadership and Collaborations:
Dr. Shuaib is director of the University of Alberta Stroke Program which, in 2016, launched the first stroke ambulance in Alberta. He chairs the National Stroke Program and the National Residents’ Review Course and is on the board of the Canadian Stroke Consortium. He is very involved in clinical trials and is currently on steering committees of five large multicenter acute stroke trials. Previously, he chaired the steering committees of large multicentre trials of the SAINT II and SENTIS trials. In Qatar he has started a clinical trial in patients with TIAs and minor stroke with ten participating sites in the Middle East. During his time as divisional director of Neurology in the Department of Medicine, he started a stroke prevention clinic in Edmonton and established a stroke investigative unit at the University of Alberta Hospital.
Dr. Shuaib’s clinical stroke program currently has nine neurologists with specialist stroke training and four to five fellows in training (one-to-two-year fellowship program), making it one of the largest such training programs in the country.
Dr. Shuaib’s major interests are in the understanding of the basic mechanisms of cerebral ischemia and developing clinical trials in cerebrovascular diseases. He has published over 400 articles in peer-reviewed journals and his research funding includes support from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Alberta, National Institutes of Health, the former Alberta Heritage Foundation for Medical Research and industry. He is on the editorial board of Stroke, Neurohospitalist, Journal of Neuroscience (Pakistan), Post-Graduate Journal (Pakistan), Heart Org, and is an associate editor of Frontiers in Neuroscience and Faculty F-1000.
clinical trials in acute stroke and stroke prevention, mechanisms of ischemia, translational research in stroke